Spontaneous Parkinsonism Is Associated With Cognitive Impairment in Antipsychotic-Naive Patients With First-Episode Psychosis: A 6-Month Follow-up Study

被引:67
|
作者
Cuesta, Manuel J. [1 ]
Sanchez-Torres, Ana M. [1 ]
Garcia de Jalon, Elena [1 ]
Campos, Maria S. [1 ]
Ibanez, Berta [2 ]
Moreno-Izco, Luca [1 ]
Peralta, Victor [1 ]
机构
[1] Complejo Hosp Navarra, Psychiat Unit B, Pamplona 31008, Spain
[2] Fdn Miguel Servet, Biomed Res Ctr, Methodol Unit, Pamplona, Spain
关键词
schizophrenia; neuropsychological impairment; cognition; extrapyramidal signs; abnormal movements; MOVEMENT-DISORDERS; SPONTANEOUS DYSKINESIA; SCHIZOPHRENIC-PATIENTS; NEUROLOGICAL SIGNS; NEGATIVE SYMPTOMS; MOTOR; SCALE; DISEASE; ILLNESS; PSYCHOPATHOLOGY;
D O I
10.1093/schbul/sbt125
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There is now growing evidence that parkinsonism and other extrapyramidal signs are highly prevalent in patients with first-episode psychosis who have never been exposed to antipsychotic drugs. However, the neuro-cognitive correlates of parkinsonism in this population remained to be clarified. A sample comprising 100 consecutive drug-naive patients with first-episode psychosis were enrolled on the study and followed up for 6 months. Seventy-seven completed assessments at 3 time points (baseline, 1 mo, and 6 mo), involving clinical and cognitive examinations and a specific assessment of motor abnormalities. The Simpson-Angus Scale (SAS) was used for the assessment of extrapyramidal signs, and each motor domain was evaluated with a standard assessment scale. Linear mixed models were built to explore the longitudinal relationships between parkinsonism scores and cognitive impairment. Parkinsonism scores showed significant strong longitudinal associations with deficits in memory, executive functioning, and attention. Spontaneous parkinsonism (total SAS score and hypokinesia and rigidity subscores at baseline) showed high 6-month predictive values for cognitive impairment. In addition, they also had high predictive values for neurologic soft-sign abnormalities but not for dyskinesia, akathisia, and pure catatonic abnormalities. No predictive value was found for glabella-salivation or tremor subscores on the SAS scale. These results emphasize the relevance of the assessment of parkinsonism signs prior to starting to administer antipsychotic drugs, as core manifestations of psychotic illness with a high predictive value for cognitive impairment.
引用
收藏
页码:1164 / 1173
页数:10
相关论文
共 50 条
  • [21] SENSORIMOTOR GATING IN FIRST-EPISODE, ANTIPSYCHOTIC-NAIVE SCHIZOPHRENIA PATIENTS: A LONGITUDINAL STUDY
    Aggernaes, Bodil
    Oranje, B.
    Glenthoj, B.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 46 - 47
  • [22] Stability of prepulse inhibition and habituation of the startle reflex in schizophrenia: a 6-year follow-up study of initially antipsychotic-naive, first-episode schizophrenia patients
    Hammer, Trine Bjorg
    Oranje, Bob
    Fagerlund, Birgitte
    Bro, Hannah
    Glenthoj, Birte Y.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011, 14 (07): : 913 - 925
  • [23] Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis
    Lee, Maria
    Cernvall, Martin
    Borg, Jacqueline
    Plaven-Sigray, Pontus
    Larsson, Cornelia
    Erhardt, Sophie
    Sellgren, Carl M.
    Fatouros-Bergman, Helena
    Cervenka, Simon
    [J]. JAMA PSYCHIATRY, 2024,
  • [24] Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity
    Eric Plitman
    Raihaan Patel
    Jun Ku Chung
    Jon Pipitone
    Sofia Chavez
    Francisco Reyes-Madrigal
    Gladys Gómez-Cruz
    Pablo León-Ortiz
    M Mallar Chakravarty
    Camilo de la Fuente-Sandoval
    Ariel Graff-Guerrero
    [J]. Neuropsychopharmacology, 2016, 41 : 2606 - 2613
  • [25] Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity
    Plitman, Eric
    Patel, Raihaan
    Chung, Jun Ku
    Pipitone, Jon
    Chavez, Sofia
    Reyes-Madrigal, Francisco
    Gomez-Cruz, Gladys
    Leon-Ortiz, Pablo
    Chakravarty, M. Mallar
    de la Fuente-Sandoval, Camilo
    Graff-Guerrero, Ariel
    [J]. NEUROPSYCHOPHARMACOLOGY, 2016, 41 (10) : 2606 - 2613
  • [26] Metabolic syndrome in antipsychotic-naive patients with first-episode psychosis: a systematic review and meta-analysis
    Garrido-Torres, Nathalia
    Rocha-Gonzalez, Idalino
    Alameda, Luis
    Rodriguez-Gangoso, Aurora
    Vilches, Ana
    Canal-Rivero, Manuel
    Crespo-Facorro, Benedicto
    Ruiz-Veguilla, Miguel
    [J]. PSYCHOLOGICAL MEDICINE, 2021, 51 (14) : 2307 - 2320
  • [27] Antipsychotic drug treatment in first-episode mania: A 6-month longitudinal study
    Zarate, CA
    Tohen, M
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (01) : 33 - 38
  • [28] Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
    Ballesteros, Alejandro
    Sanchez-Torres, Ana M.
    Lopez-Ilundain, Jose M.
    Cabrera, Bibiana
    Lobo, Antonio
    Gonzalez-Pinto, Ana M.
    Diaz-Caneja, Covadonga
    Corripio, Iluminada
    Vieta, Eduard
    de la Serna, Elena
    Bobes, Julio
    Usall, Judith
    Contreras, Fernando
    Lorente-Omenaca, Ruth
    Mezquida, Gisela
    Bernardo, Miguel
    Cuesta, Manuel J.
    [J]. PSYCHOLOGICAL MEDICINE, 2018, 48 (13) : 2247 - 2256
  • [29] Deficient Inhibitory Cortical Networks in Antipsychotic-Naive Subjects at Risk of Developing First-Episode Psychosis and First-Episode Schizophrenia Patients: A Cross-Sectional Study
    Hasan, Alkomiet
    Wobrock, Thomas
    Grefkes, Christian
    Labusga, Marcin
    Levold, Katrin
    Schneider-Axmann, Thomas
    Falkai, Peter
    Mueller, Hendrik
    Klosterkoetter, Joachim
    Bechdolf, Andreas
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 72 (09) : 744 - 751
  • [30] Substance misuse in first-episode psychosis: 15-month prospective follow-up study
    Wade, D.
    Harrigan, S.
    Edwards, J.
    Burgess, P. M.
    Whelan, G.
    McGorry, P. D.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2006, 189 : 229 - 234